Inventor · disambiguated record
David R. Langley
Also filed as: LANGLEY DAVID · LANGLEY DAVID R
53 granted patents·4 pending applications·718 citations·filing 1988–2022
98Inventor score
Files withBRISTOL MYERS SQUIBB CO36BACHAND CAROL6BRISTOL MYERS CO2VIIV HEALTHCARE UK NO 5 LTD2BALDWIN ERIC T1
Top patents by PatentIndex Score
57 records- 0198US7741347B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 22, 2010·52 cites·13 claims
- 0297US8303944B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2008·Granted Nov 6, 2012·36 cites·13 claims
- 0397US7704992B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 27, 2010·58 cites·25 claims
- 0497US7659270B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Feb 9, 2010·72 cites·25 claims
- 0596US9308236B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 12, 2016·51 cites·5 claims
- 0696US7759495B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 20, 2010·41 cites·31 claims
- 0796US7745636B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 29, 2010·53 cites·26 claims
- 0895US9879046B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 30, 2018·17 cites·12 claims
- 0995US9850225B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 26, 2017·13 cites·15 claims
- 1095US8574563B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Nov 5, 2013·18 cites·26 claims
- 1194US7534792B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 19, 2009·30 cites·14 claims
- 1293US10143746B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 4, 2018·9 cites·17 claims
- 1393US9856292B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 2, 2018·12 cites·32 claims
- 1492US9850283B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 26, 2017·12 cites·1 claims
- 1592US8846023B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 30, 2014·7 cites·13 claims
- 1692US8642025B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 4, 2014·12 cites·40 claims
- 1791US8147818B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Apr 3, 2012·22 cites·22 claims
- 1890US10633419B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 28, 2020·7 cites·4 claims
- 1990US9006235B2Inhibitors of human immunodeficiency virus replicationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 14, 2015·8 cites·14 claims
- 2089US10882844B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 5, 2021·4 cites·11 claims
- 2189US8492553B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Jul 23, 2013·11 cites·31 claims
- 2289US7879855B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 1, 2011·10 cites·1 claims
- 2388US9227961B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·6 cites·12 claims
- 2487US11358988B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 14, 2022·2 cites·8 claims
- 2587US10358463B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 23, 2019·7 cites·15 claims
- 2687US10144706B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 4, 2018·7 cites·8 claims
- 2787US8288562B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2010·Granted Oct 16, 2012·9 cites·31 claims
- 2884US10538555B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 21, 2020·8 cites·3 claims
- 2983US9018390B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 28, 2015·4 cites·31 claims
- 3082US11066445B2Immunomodulators acting as antagonists of PD-1BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 20, 2021·2 cites·6 claims
- 3182US8633200B2Inhibitors of human immunodeficiency virus replicationPENDRI ANNAPURNA·Filed 2011·Granted Jan 21, 2014·5 cites·13 claims
- 3282US8093243B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Jan 10, 2012·5 cites·26 claims
- 3379US11578054B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 14, 2023·2 cites·13 claims
- 3479US10745382B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 18, 2020·2 cites·25 claims
- 3579US5395849AHybrid antitumor compounds containing a cyclic enediyne and a DNA-binderBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Mar 7, 1995·19 cites·13 claims
- 3678US11952434B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 9, 2024·0 cites·6 claims
- 3778US8906929B2Inhibitors of human immunodeficiency virus replicationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 9, 2014·2 cites·15 claims
- 3877US10988507B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 27, 2021·2 cites·9 claims
- 3976US9034882B2Inhibitors of human immunodeficiency virus replicationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 19, 2015·3 cites·14 claims
- 4076US8664213B2Spiro bicyclic diamine derivatives as HIV attachment inhibitorsWANG TAO·Filed 2012·Granted Mar 4, 2014·3 cites·9 claims
- 4171US6399581B1Compound possessing potent thrombin receptor antagonist activityHARBOR BRANCH OCEANOGRAPHIC·Filed 2000·Granted Jun 4, 2002·2 cites·4 claims
- 4270US8343999B2Thiazolyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 1, 2013·1 cites·4 claims
- 4370US4965348ADimeric epipodophyllotoxin glucoside derivativesBRISTOL MYERS CO·Filed 1989·Granted Oct 23, 1990·16 cites·10 claims
- 4468US5478854ADeoxy taxolsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Dec 26, 1995·39 cites·18 claims
- 4564US4935504AEpipodophyllotoxin glucoside 4'-acyl derivativesBRISTOL MYERS CO·Filed 1988·Granted Jun 19, 1990·13 cites·43 claims
- 4663US8148400B2Thiazolyl compounds useful as kinase inhibitorsMARINIER ANNE·Filed 2007·Granted Apr 3, 2012·1 cites·5 claims
- 4761US9758487B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 12, 2017·0 cites·15 claims
- 4857US2017369530A1Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 4956US8592579B2Pyrrolotriazine kinase inhibitorsWITTMAN MARK D·Filed 2012·Granted Nov 26, 2013·0 cites·1 claims
- 5053US2024043506A1Sars-cov-2 antibodiesGARVAN INSTITUTE OF MEDICAL RES·Filed 2021·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →